Hypertransaminasemia in choledocholithiasis
DOI:
https://doi.org/10.52784/27112330.150Keywords:
choledocholithiasis, transaminases, hepatitis, bile duct.Abstract
Introduction. Acute choledocholithiasis occurs when a stone impacts the distal bile duct. It usually manifests with a cholestatic pattern, with a mild or moderate increase in ASL and ALT. However, series of cases of choledocholithiasis have been reported with AST and ALT values >400 IU/L, which may lead the physician to consider hepatitis as a presumptive diagnosis, instead of choledocholithiasis. This scoping review is intended to explain this form of presentation, and to sugges the steps that the clinician should take to identify these cases and provide a timely and accurate diagnosis. Methodology. A scoping review was carried out using PubMed, BIREME (BVS), LILACS and Google Scholar search engines, with the MeSH words “choledocholithiasis”, “transaminases” and the “and” connector, as well as the DeCS terms “coledocolitiasis”, “transaminasas” and the “y” connector. Results. A total of 20 studies related to the topic of choledocholithiasis and elevation of AST or ALT >400 IU/L were included in the analysis. It was found that the increase in AST or ALT between 400 IU/L and 500 IU/L occurred in 5.76% of the cases, values between 500 IU/L and 800 IU/L in 36.8%, between 800 IU/L and 1,000 IU/L in 9%, and values >1,000 IU/L in 6.43% of the cases. Conclusion. Choledocholithiasis with elevated AST or ALT transaminases >400 IU/L is an occurrence that should be taken into account, particularly in young people, and in those without a history of previous liver problems. It is necessary for the specialist to have a presumptive diagnosis of choledocholithiasis, even with transaminase levels that may suggest hepatitis, and to analyze the different variables that are essential to achieve an accurate diagnosis.
Downloads
References
Bangaru S, Thiele D, Sreenarasimhaiah J, Agrawal D. Severe elevation of liver tests in choledocholithiasis: An uncommon occurrence with important clinical implications. J Clin Gastroenterol 2017;51:728-733. https://doi.org/10.1097/mcg.0000000000000608.
Benites-Goñi HE, Palacios-Salas FV, Asencios-Cusihuallpa JL, Aguilar-Morocco R, Segovia-Valle NS. Rendimiento de los criterios predictivos de la ASGE en el diagnóstico de coledocolitiasis en el Hospital Edgardo Rebagliati Martins. Rev Gastroenterol Perú 2017;37:111-119.
Isogai M, Hachisuka K, Yamaguchi A, Nakano S. Etiology and pathogenesis of marked elevation of serum transaminase in patients with acute gallstone disease. HPB Surg 1991;4:95-107. https://doi.org/10.1155/1991/95059.
Souto N, Ovaldi N. Marcadores de coledocolitiasis en patología biliar aguda. Rev Argent Cir 1988;54:209-213.
Velázquez-Mendoza J, Medina-Doroteo A, Vega-Malagón A. Factores predictivos para el diagnóstico temprano de coledocolitiasis. Cir Gen 2010;32:39-44.
Yriberry-Ureña S, Monge-Zapata V. Pruebas de laboratorio como predictores de coledocolitiasis en pacientes sometidos a CPRE: experiencia en un centro privado nacional. Rev Gastroenterol Perú 2007;27:253-258.
González-Pérez LG, Zaldívar-Ramírez FR, Tapia-Contla BR, et al. Risk factors for asymptomatic choledocholithiasis; experience at the Hospital General de México. Cir Gen 2018;40:164-168.
Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005;172:367-379. https://doi.org/10.1503/cmaj.1040752.
Colquhoun HL, Levac D, O'Brien KK, Straus S, Tricco AC, Perrier L, et al. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol 2014;67:1291-1294. https://doi.org/10.1016/j.jclinepi.2014.03.013.
Mossberg SM, Bloom A, Berkowitz J, Ross G. Serum enzyme activities following morphine. A study of transaminase and alkaline phosphatase levels in normal persons and those with gallbladder disease. Arch Intern Med 1962;109:429-437. https://doi.org/10.1001/archinte.1962.03620160055008.
Gardner B. Marked elevation of serum transaminases in obstructive jaundice. Am J Surg 1966;111:575-579. https://doi.org/10.1016/0002-9610(66)90288-1.
Abbruzzese A, Jeffery RL. Marked elevations of serum glutamic oxalacetic transaminase and lactic dehydrogenase activity in chronic extraheptic biliary disease. Am J Dig Dis 1969;14:332-338. https://doi.org/10.1007/bf02235945.
Ginsberg AL. Very high levels of SGOT and LDH in patients with extrahepatic biliary tract obstruction. Am J Dig Dis 1970;15:803-807. https://doi.org/10.1007/bf02236040.
Fortson WC, Tedesco FJ, Starnes EC, Shaw CT. Marked elevation of serum transaminase activity associated with extrahepatic biliary tract disease. J Clin Gastroenterol 1985;7:502-505. https://doi.org/10.1097/00004836-198512000-00012.
Nathwani RA, Kumar SR, Reynolds TB, Kaplowitz N. Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis. Am J Gastroenterol 2005;100:295-298. https://doi.org/10.1111/j.1572-0241.2005.40793.x.
Keswani RN, Hart J, Mohanty SR. A patient with abdominal pain and markedly elevated transaminase levels after cholecystectomy. Nat Clin Pract Gastroenterol Hepatol 2006;3:468-472. https://doi.org/10.1038/ncpgasthep0556.
Jeon WJ, Han JH, Seo JC, Park SM, Chae HB, Youn SJ. [Clinical features of patients with choledocholithiasis showing high levels of aminotransferases]. Korean J Gastroenterol 2006;47:213-217.
Sharara AI, Mansour NM, El-Hakam M, Ghaith O, El Halabi M. Duration of pain is correlated with elevation in liver function tests in patients with symptomatic choledocholithiasis. Clin Gastroenterol Hepatol 2010;8:1077-1082. https://doi.org/10.1016/j.cgh.2010.08.021.
Agahi A, McNair A. Choledocholithiasis presenting with very high transaminase level. BMJ Case Rep 2012;2012:bcr2012007268. https://doi.org/10.1136/bcr-2012-007268.
Tetangco EP, Shah N, Arshad HM, Raddawi H. Markedly elevated liver enzymes in choledocholithiasis in the absence of hepatocellular disease: Case series and literature review. J Investig Med High Impact Case Rep 2016;4:2324709616651092. https://doi.org/10.1177/2324709616651092.
Huh CW, Jang SI, Lim BJ, Kim HW, Kim JK, Park JS, et al. Clinicopathological features of choledocholithiasis patients with high aminotransferase levels without cholangitis: Prospective comparative study. Medicine (Baltimore) 2016;95:e5176. https://doi.org/10.1097/md.0000000000005176.
Vecchi-Ferri JV, Moreira-Dias da Silva JP, Oliveira-Filho Ud, Fronero-Bicca JA, Brito-de Araujo D. High levels of transaminases in a choledocholithiasis case: the importance of knowing this pattern. Rev Med 2017;96:131-133. https://doi.org/10.11606/issn.1679-9836.v96i2p131-133.
Björnsson HK, Björnsson ES. A significant proportion of patients with choledocholithiasis have markedly elevated alanine aminotransferase. Scand J Gastroenterol 2019;54:1155-1159. https://doi.org/10.1080/00365521.2019.1657177.
Yurgaky-Sarmiento J, Otero-Regino W, Gómez-Zuleta MA. Elevación de las aminotransferasas: una nueva herramienta para el diagnóstico de coledocolitiasis. Un estudio de casos y controles. Rev Colomb Gastroenterol 2020;35:319-328. https://doi.org/10.22516/25007440.446.
Mossberg SM, Ross G. High serum transaminase activity associated with extrahepatic biliary disease. A clinical and pathologic study of sixty patients with serum glutamic-oxalacetic transaminase levels of 300 units or greater. Gastroenterology 1963;45:345-353.
Pavlidis ET, Pavlidis TE. Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int 2018;17:17-21. https://doi.org/10.1016/j.hbpd.2018.01.008.
Bachar GN, Cohen M, Belenky A, Atar E, Gideon S. Effect of aging on the adult extrahepatic bile duct: a sonographic study. J Ultrasound Med 2003;22:879-882. https://doi.org/10.7863/jum.2003.22.9.879.
Perret RS, Sloop GD, Borne JA. Common bile duct measurements in an elderly population. J Ultrasound Med 2000;19:727-730. https://doi.org/10.7863/jum.2000.19.11.727.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |















